Clinical trial Recruiting at 1 site Interventional

Minimally Invasive Injectable Platelet Concentrate for Deep Pockets in Periodontitis

Official title: The Effect of Adjunctive I-PRF on the Outcomes of Minimally-invasive Non-surgical Therapy of Periodontal Intrabony Defects.A Randomized Clinical Trial

Run by Cairo University · NCT07722390 · Data updated 2026-11-12

This study tests whether adding injectable platelet concentrate to a minimally invasive nonsurgical procedure can reduce deep periodontal pockets in people with intrabony defects.

Quick facts

Study typeInterventional
SexAll
Enrollment48 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedMay 14, 2025
Main results expectedDecember 2027
Study endsJune 2028
Registry record updatedJuly 29, 2026
Trial IDNCT07722390 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with stage III–IV periodontitis, at least one intrabony defect (≥3 mm radiographic depth) and PPD ≥ 6 mm, post-initial therapy, non-smokers.

Probably not a fit

Patients with smoking history or contributory systemic conditions may have limited or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study evaluates a minimally invasive non-surgical approach combined with injectable platelet concentrate for treating intrabony periodontal defects in adults with stage III–IV periodontitis. Eligible participants have at least one intrabony defect (≥3 mm radiographic depth) and a pocket depth of 6 mm or more, after initial therapy. The procedure involves delivering injectable platelet concentrate alongside a MINST technique, with follow-up through 6 months to assess pocket depth changes. Participants must be non-smokers or never-smokers and able to consent and complete follow-up. There is no listed funding from multiple centers; Cairo University leads the trial in Cairo, Egypt.

Why it matters

Potential benefit: If successful, patients could experience greater reduction in pocket depth and better healing of deep periodontal defects.

How similar studies have gone: Prior studies using platelet concentrates in periodontal pockets have shown promise, but results vary depending on technique and defect characteristics.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with periodontitis stage III-IV.
* Presence of at least one intrabony defect with radiographic component ≥ 3mm deep and PPD≥ 6mm (not affecting a tooth with 'hopeless' prognosis).
* Patients willing to sign informed consent and to be in the study until the 6-months follow-up.
* Full-mouth plaque score \<30% following step 1 periodontal therapy

Exclusion Criteria:

* Smoker/vaper (currently or in past 5 years).
* Contributory medical history (e.g. cardiovascular disease, diabetes, psychiatric conditions).

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.